Every few months for the past three years, Jeff Vierstra has been receiving infusions in his spine that target and disable a mutated gene that made it likely he would develop ALS.
Columbia's Silence ALS program is testing spinal antisense therapy in a high‑risk patient; early EMG tests normalized.
New rare genetic variants are linked to ALS, expanding understanding of genetic contributors. About a quarter of ALS cases have an identifiable genetic contributor. Findings support broader use of ...
There is a rare gene mutation linked to sudden cardiac death and heart failure called phospholamban (PLN). It may not be very ...
Scientists have traced a devastating pattern of brain cell loss in a handful of families to a single, ultra-rare mutation that sabotages one of the brain’s key protective enzymes. The discovery not ...
Scientists have identified rare genetic mutations granting extraordinary abilities, including minimal sleep, extreme strength ...
Susannah Rosen was diagnosed with a KIF1A gene mutation at the age of 2½. Patients diagnosed with severe KIF1A gene mutations may live only into early childhood, while patients with mild symptoms can ...